Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2026-03-02 @ 3:42 PM
Study NCT ID:
NCT02047734
Status:
COMPLETED
Last Update Posted:
2021-02-11
First Post:
2014-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12-03
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-13
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-26
First Submit QC Date:
None
Study First Post Date:
2014-01-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-01-25
Results First Submit QC Date:
None
Results First Post Date:
2021-02-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-04-06
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-01-25
Last Update Post Date:
2021-02-11
Last Update Post Date Type:
ACTUAL